Junichi Iwamoto

Dr. Junichi Iwamoto

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JIJunichi Iwamoto
Junichi Iwamoto
YSYoshifumi Saito
Yoshifumi Saito
AHAkira Honda
Akira Honda
YMYasushi Matsuzaki
Yasushi Matsuzaki
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy

23 April 2018 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
MMMasashi Murakami
Masashi Murakami
JIJunichi Iwamoto
Junichi Iwamoto
AHAkira Honda
Akira Honda
TTTakeshi Tsuji
Takeshi Tsuji
MTMakoto Tamamushi
Makoto Tamamushi
YMYasushi Matsuzaki
Yasushi Matsuzaki
Dysbiosis, especially a reduced Clostridium subcluster XIVa (XIVa), has been reported in several gastrointestinal diseases. Since XIVa is thought to be the main bacterial cluster that metabolizes bile acids (BAs) in the human intestine, we hypothesized that the BA profile in feces, and possibly in serum, could be a convenient biomarker for intestinal XIVa activity. First, blood and feces were collected from 26 healthy controls and 20 patients with gastrointestinal diseases, and the relationships among fecal microbiomes and fecal and serum BA compositions were studied. Second, serum BA compositions of 30 healthy controls and the remission and exacerbation states of 14 Crohn’s disease (CD) and 12 ulcerative colitis (UC) patients were compared. Fecal microbiomes were analyzed by terminal restriction fragment length polymorphism analysis, and BA compositions were quantified by HPLC-MS/MS. The highest positive correlation was observed between the fecal XIVa proportion and fecal unconjugated deoxycholic acid (DCA)/(DCA+unconjugated cholic acid [CA]) (r = 0.77, P < 0.0001) or serum DCA/(DCA+CA) (r = 0.52, P < 0.001). Diurnal variation in serum XIVa candidate markers also showed that DCA/(DCA+CA) was most stable and not affected by the contraction of the gallbladder. Serum DCA/(DCA+CA) was not significantly different between remission and exacerbation states in either CD or UC patients, but was significantly reduced in those in the remission state of CD and the remission and exacerbation states of UC compared with healthy controls (P < 0.05). Decreased XIVa exhibits a strong correlation with reduced intestinal BA metabolism. Fecal and serum DCA/(DCA+CA) could be useful surrogate markers for the intestinal proportion of XIVa.

15 September 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
Teruo MiyazakiTeruo Miyazaki
Teruo Miyazaki
AHAkira Honda
Akira Honda
TITadashi Ikegami
Tadashi Ikegami
JIJunichi Iwamoto
Junichi Iwamoto
TMTadakuni Monma
Tadakuni Monma
YMYasushi Matsuzaki
Yasushi Matsuzaki
We have developed a highly sensitive and specific method for quantification of salivary 3-hydroxybutyrate (3HB), 3-hydroxyisobutyrate (3HIB), 3-hydroxy-3-methylbutyrate (3HMB) and 2-hydroxybutyrate (2HB), which could be new non-invasive biomarkers for catabolic pathways of fatty acids/ketogenic amino acids, valine, leucine, and methionine/threonine/α-ketobutyrate, respectively. The four hydroxybutyrates (3HB, 3HIB, 3HMB, and 2HB) were extracted from 5 µl of saliva, converted to 2-pyridylmethyl (2PM) ester derivatives, and measured by liquid chromatography–tandem mass spectrometry in positive electrospray ionization mode. [13C4]3HB was used as an internal standard. The detection limits for the 2PM esters were <1 pg (7.9–9.6 fmol) on-column (signal-to-noise ratio = 3). Reproducibilities and recoveries of the hydroxybutyrates were validated according to one-way layout and polynomial equation, respectively. The variances between sample preparations and between measurements were calculated to be 0.45–5.28 and 0.54–3.45 %, respectively. Experiments performed using 5 µl of saliva spiked with 3.8–154.4 pmol of the four hydroxybutyrates gave recoveries of 98.5 to 108.8 %, with a mean recovery of 104.1 %. In vitro experiments in hepatocytes or skeletal muscle cells showed that addition of palmitic acid, valine, leucine or α-ketobutyrate to culture medium markedly increased the targeted hydroxybutyrate concentrations. The salivary concentration of each targeted hydroxybutyrate was positively correlated with that in serum, and the salivary levels were elevated in patients with liver cirrhosis, which is characterized by upregulated catabolism of lipids and amino acids. The proposed method is useful for quantification of salivary 3HB, 3HIB, 3HMB, and 2HB for monitoring of catabolic activities of amino acids and fatty acids.

1 May 2013 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
JIJunichi Iwamoto
Junichi Iwamoto
YSYoshifumi Saito
Yoshifumi Saito
AHAkira Honda
Akira Honda
Teruo MiyazakiTeruo Miyazaki
Teruo Miyazaki
TITadashi Ikegami
Tadashi Ikegami
YMYasushi Matsuzaki
Yasushi Matsuzaki
Background. Recent studies have suggested that the downregulation of pregnane X receptor (PXR) may contribute to the susceptibility and exacerbation of Crohn’s

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JIJunichi Iwamoto
Junichi Iwamoto
YMYuji Mizokami
Yuji Mizokami
YSYoshifumi Saito
Yoshifumi Saito
KSKoichi Shimokobe
Koichi Shimokobe
AHAkira Honda
Akira Honda
YMYasushi Matsuzaki
Yasushi Matsuzaki
Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding

1 January 2005 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
JIJunichi Iwamoto
Junichi Iwamoto
YMYuji Mizokami
Yuji Mizokami
KTKimiko Takahashi
Kimiko Takahashi
KNKazuhiko Nakajima
Kazuhiko Nakajima
TOToshiya Ohtsubo
Toshiya Ohtsubo
TMTakeshi Matsuoka
Takeshi Matsuoka
Destruction of the extracellular matrix is essential for tumor invasion and metastasis. The relationship between Helicobacter pylori (H. pylori) infection and destruction of the extracellular matrix is not yet clear. Urokinase-type plasminogen activator (uPA) plays an important role in the destruction of the extracellular matrix and basement membrane. Urokinase-type plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1(PAI-1) appear to be associated with these processes. To clarify the role of H. pylori infection in the processes of destruction of the extracellular matrix and basement membrane in cancerous tissue, the effect of H. pylori on the expressions of uPA, uPAR and PAI-1 in cancer cells was investigated. Material and methods Gastric cancer cell lines (MKN45, KATO-III) were co-cultured with H. pylori standard strain (NCTC11637), cagA-negative strain and clinical isolated strain. The specific inductions of uPA, uPAR and PAI-1 mRNA were examined by reverse transcription-polymerase chain reaction (RT-PCR) amplification. The secreted uPA antigen was measured by enzyme-linked immunosorbent assay (ELISA). To evaluate the role of transcription factor NF-κB in uPA and uPAR gene transcription with H. pylori stimulation, the effect of NF-κB inhibitor MG132 on H. pylori-induced uPA and uPAR mRNA expression was examined. Results The expressions of both uPA and uPAR mRNAs in the gastric cancer cell lines (MKN45 and KATO- III) were increased markedly (uPA mRNA; MKN45: 12-fold, KATO-III: 5-fold) (uPAR mRNA; MKN45: 3-fold, KATO-III: 3-fold) with H. pylori NCTC11637 strain stimulation, whereas the expression levels of uPA and uPAR mRNA did not increase with cagA-negative strain stimulation. These cancer cell lines slightly secreted uPA antigen into the culture medium, and the amount of uPA antigen increased dramatically by stimulation with H. pylori NCTC11637 and cagA-positive clinical isolated strains. These gastric cancer cell lines also slightly secreted PAI-1 antigen into the culture medium, and the amount of PAI-1 antigen was not affected by H. pylori NCTC11637 stimulation. H. pylori-induced uPA and uPAR mRNA expressions were strongly down-regulated by pretreatment with MG132 in both cell lines. Conclusions The results of this study indicated the possibility that cagA-positive H. pylori may play an important role not only in tissue remodeling, angiogenesis and wound healing but also in the process of degradation of the extracellular matrix breakdown, tumor invasion and metastasis by inducing uPA and uPAR complex in the gastric cancer cells.